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ABSTRACT: Cardiospermum halicacabum used in Ayurveda has been investigated for various 
pharmacological actions in a number of experimental animal models.  On central nervous 
system the decoction of the plant showed sedative effect.  It exhibited significant analgesic and 
anti-inflammatory activities.  The drug also showed vasadepressant activity which is considered 
to be transcient in nature.  In vitro studies also revealed its antispasmodic effect.  These findigns 
are in support of its use in Ayurvedic medicine. 
 
INTRODUCTION 
 
C. halicacabum (Jyotishmati) has been 
described in Ayurveda as a remedy in the 
treatment of rheumatism, piles, bronchitis 
and nervous diseases.  Decoction of the 
plant is considered as diuretic, diaphoretic 
and laxative
1.  Recently, diuretic activity of 
the plant in experimental animals has 
already been reported
2.  However, there are 
not much reports on the other 
pharmacological effects of this medicinal 
plant and hence the present study was 
initiated to probe into its medicinal value 
using the aqueous extract (decoction) of the 
whole plant. 
 
MATERIALS AND METHODS 
 
Pharmacognostically identified, shade dried 
whole plant was used to prepare the 
decoction as described by Nadkarni (1954)
3.  
Albion rats, mice, g. pigs and dogs were 
used in the experiments and the drug 
decoction was given orally to them as 
otherwise indicated.  Drug dose levels were 
calculated in terms of crude drug / kg body 
weight. 
 
i.  Acute toxicity and general 
behaviour: 
 
Groups of 6 mice were used for each dose 
level with a control group receiving distilled 
water only.  Overnight fasted albino mice 
were used for this study as described by 
Irwin (1963)
4.  Test drug decoction was 
given orally in dose levels of 1,5,10,20,30 
and 50g/kg body wt.  Behavioural changes 
were observed at 15,30,60, 120 and 240 min 
afer drug and for tonic effects and mortality 
up to 72 hrs. 
 
ii.  Effect on pentobarbitone hypnosis: 
 
Test drug decoction was given to overnight 
fasted mice in dose levels of 1 to 20 g / kg 
and 30 min later pentobarbitone sodium was 
injected (50 mg/kg i.p) to all of them.   
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instead of the decoction.  The period 
between the loss and the return of righting 
reflex was taken as the sleeping time and 
compared this with that of control. 
 
iii.  Anticonvulsant activity: 
 
The effect of various doses of decoction of 
C. halicacabum (1, 5, 10,15 and 20 g / kg) 
was studied against maximal electroshock 
seizure test (150 mA, 0.2 sec) in male rats 
according to the method of Holland et al 
(1961)
5.  Percentage protection from 
convulsions was noted.  Dilantin sodium 
(100 mg/kg p.o) was used as reference 
standard for comparison. 
 
iv.  Analgesic activity: 
 
This was studied by the rat tail flick method 
using hotwire analgesiometer
6.  Drug 
decoction was administered orally (1,5,10 & 
20g/kg) and acetylsalicylic acid (500 mg/kg 
p.o) was used as the standard drug. 
 
v.  Anti – inflammatory activity: 
 
Drug decoction was screened against both 
acute and chronic types of inflammation. 
 
a)  Mouse ear oedema test; Method of 
Brown and Robson (1964)
7  with 
some modifications was adopted to 
study the effect of drug decoction 
(1,2,5 & 10g/kg ) in this acute 
inflammatory process.  The 
difference between the mean oedema 
of the drug treated group  and the 
control was calculated and expressed 
as percent inhibition.   
Phenylbutazone (100 mg/kg) was 
used as the standard drug for 
comparison. 
 
b)  Croton oil induced granuloma in 
rats: Method of Selye (1953)
8  with 
modification was followed.  Test 
drug decoction was administered in 
two dose levels of 10 and 20 g/kg 
with a control group receiving 
distilled water and another group 
receiving phenylbutazone (100 
mg/kg) as standard drug.  The 
inhibitory effect on the granuloma 
formation was assessed by 
measuring the  fluid accumulation 
and noting the weight of the pouch 
wall. 
 
vi.  Effect on arterial – blood pressure of 
anesthetized dog: 
 
Mongrel dogs of either sex (10 –  15 kg) 
were anesthetized with pentobarbitone 
sodium (35 mg / kg  i.p).  The drug 
decoction was injected  intravenously by 
cannulating femoral vein and carotid 
pressure was monitored through a mercury 
manometer.  Since the drug decoction 
elicited vasodepressor response the mode of 
action  was  evaluated  in  β-blocker 
(propranolol  –  5 mg/kg) antihistamine 
(anthisan  –  10 mg/kg) or anticholinersic 
agent (atropine –  2 mg/kg) pretreated 
animals.  The effect of decoction on normal 
responses of adrenaline, Ach and nicotine 
was also studied. 
 
vii.  Effect on perfused frog heart (in – 
situ): 
 
Contractions of the perfused frog heart was 
recorded on the smoked paper in a slow 
moving drum using starling heart lever.  
Decoction in varying dose levels was 
injected into the perfusing fluid in a constant 
volume and changes in the rate and force of 
contractions were recorded
9. 
 
viii.  Antifertility activity: 
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A preliminary study to detect the effect of 
drug decoction (1,2,5 & 10 g/kg) on 
implantation activity in mated Holtzman 
female rats (D1 – D5) was carried out.  On 
D10 of pregnancy they were leparatomised 
and uterine horns examined for the number 
and size of implants
10. 
 
ix.  Autonomic pharmacology (in – vitro 
tests): 
 
a)  On isolated ileum of guinea pig: 
 
Longitudinal contractions of ileum to 
alternate doses of acetylcholine and 
histmine (1 – 2 µg/ml) were recorded as 
described by Burn (1952)
9.  The tissue 
was suspended in Krebs’ solution (37
oC) 
and 3 min dose cycle was used.  Test 
drug in various doses (in terms of crude 
drug) was added to the bath in a constant 
volume and the effect of Acetylcholine 
and histamine was noted.  
 
b)  On rabbit jegunum: 
 
Effect of  Acetylcholine, adrenaline (0.1 
to 1 µg/ml) and test drug (up to 500 
mg/ml) on the contractions of rabbit 
jejunum suspended in tyrode solution 
(37
oC) was noted.  Effect of decoction 
pretreatment on the spasmogenic effect 
of Acetylcholine and relaxation effect of 
adrenaline was also studied in a number 
of tissue preparations. 
 
c)  On the rectus abdominis muscle of frog: 
 
The test was carried out as described by 
Burn (1952)
9.  Effect of decoction (10 
mg to 100 mg) on the Acetylcholine 
induced spasm was studied. 
 
TABLE – I 
Effect of C. Halicacabum on xylol induced acute mouse ear oedema 
 
  Drug  Dose g/mg/kg 
(p.o.) 
n  Oedema (mg) 
Mean ± S. E. 
% inhibition 
of Oedema 
i.  
 
 
ii. 
 
 
iii. 
 
 
iv. 
 
 
v. 
 
vi. 
 
C. halicacabum 
 (decoction) 
 
C. halicacabum 
 (decoction) 
 
C. halicacabum 
 (decoction) 
 
C. halicacabum 
 (decoction) 
 
Controls Dist. Water 
 
Phenylbutazone 
1g 
 
 
2g 
 
 
5g 
 
 
10g 
 
 
- 
 
100 mg 
6 
 
 
6 
 
 
8 
 
 
12 
 
 
6 
 
8 
38.57 ± 6.99 
 
 
42.33 ± 6.31 
 
 
33.00 ± 10.24 
 
 
14.33 ±
a 2.07 
 
 
48.66 ± 7.60 
 
25.85 ±
b 2.80 
20.73 
 
 
13.00 
 
 
32.18 
 
 
70.55 
 
 
- 
 
46.87 
 
 
n = number of mice in the group 
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TABLE – II 
 
Effect of C. halicacabum on croton oil induced granuloma in rats 
 
  Treatment (g/mg/kg) 
(p.o.) 
n  Volume of 
inflammatory 
exudates 
(ml ± S. E.) 
Weight of 
the Pouch 
g ± S. E. 
Weight of 
adrenals 
g ± S. E. 
 
i. 
 
 
ii. 
 
 
iii. 
 
 
iv. 
 
 
Controls – Dist. Water 
 
 
Phenylbutazone – 100 mg 
 
 
C. Halicacabum – 10 g 
 
 
C. Halicacabum – 20 g 
 
6 
 
 
6 
 
 
6 
 
 
6 
 
3.05 ± 0.06 
 
 
1.31 ±
c 0.01 
 
 
1.86 ±
c 0.02 
 
 
1.42 ±
c 0.04 
 
3.71 ± 0.51 
 
 
2.01 ± 
a 0.06 
 
 
3.02 ± 0.02 
 
 
2.12 ±
b 0.01 
 
 
0.036 ± 0.003 
 
 
0.044 ± 0.002 
 
 
0.046 ± 0.002 
 
 
0.047 ± 0.002 
 
n = number of rats in the group 
p values – a <0.005, b- <0.02, c - <0.001 
 
RESULTS AND DISCUSSION 
 
Acute toxicity and general behaviour: 
 
C. halicacabum decoction did note exhibit 
any toxic symptoms or mortality in mice 
upto 50 g/ kg dose level. 
 
On pentobarbitone hypnosis: 
 
Drug decoction in dose level of 2g/ kg 
onwards showed potentiation of 
pentobarbitone hypnosis and at 8 and 20g / 
kg there was significant effect (p<0.05) 
indicating CNS sedative activity. 
 
Anticonvulsant activity: 
 
Up to 20 g / kg test drug did not afford any 
protection to rats exposed to electro shock 
seizures. 
 
Analgesic activity: 
 
At 10 and 20 g/kg doses drug exhibited 
significant analgesic activity in rats with 
maximum activity 60 min after drug 
administration similar to acetylsalicylic acid, 
the standard drug used for comparison.   
However acetysalycylic acid (500 mg/kg) 
was found to be superior in activity. 
 
Anti – inflammatory activity: 
 
Effects of C. Halicacabum on acute and 
chronic inflammatory process induced by 
xylol and croton oil are summarized in table 
1 and 2, respectively.  In acute inflammation 
in mouse, the test drug in 10 g / kg dose 
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protection from oedema.  It showed 70% 
inhibition of oedema as compared to 46% of 
phenylbutazone.  Similarly in chronic 
inflammatory process drug decoction 10 and 
20 g / kg showed very significantly (p < 
0.001) reduced the inflammatory exudate 
with reduction in weight of pouch wall.   
This activity was almost similar to that of 
phenylbutazone (100 mg/kg). 
 
On blood pressure in anesthetized dogs: 
 
Drug decoction up to 250 mg / kg did not 
exhibit any effect on blood pressure and 
respiration.  But from 500  mg/kg onwards 
there was hypotensive effect and this did not 
modify the action of acetylcholine, 
adrenaline or histamine.  However atropine 
partially blocked this hypotensive effect. 
 
On perfused frog hear (in-situ): 
 
Decoction from 100 mg onwards produced 
negative inotropic and chronotropic effect 
with a transcient arrest in diastole which 
lasted for 3 –  5 min depending upon the 
dose.  This cardiac arrest was not blocked by 
atropine and drug did not potentiate the 
negative inotropic action of acetylcholine.  
At 2000 mg and above the drug exhibited 
complete cardiac arrest. 
 
Antifertility activity: 
 
Test drug up to 10 g/ kg did not exhibit any 
anti – implantation effect in female rats. 
 
On isolated G. pig ileum: 
 
Decoction in 200 mg/ml bath fluid 
completely blocked the sparmogenic effect 
of Acetylcholine and histamine (500 ng/ml). 
 
 
 
 
On rabit jejunum: 
 
Test drug from 100 mg/ml showed 
relaxation of smooth muscle of intestine and 
blocked the sparmogenic effect of 
acetylcholine completely. 
 
On frog recuts abdominis: 
 
At 100 mg/ml, test decoction exhibited 
marked curare like action by blocking the 
spasmogenic effect of acetylcholine. 
 
Present preliminary investigations on the 
aqueous extract of C. halicacabum,  it was 
observed that this plant possessed marked 
central nervous system (CNS) effects 
without any acute toxic effects up to 50 g/kg 
orally.  From its significant analgesic effect 
as well as potentiation of pentobarbitone 
hypnosis the drug can be presumed as a 
CNS sedative.  However it failed to show 
any anti-convulsant property.  Test drug also 
showed significant anti –  inflammatory 
effect in both acute and chronic 
experimental models.  Cardiovascular 
studies exhibited myocardial depressant 
effect more or less similar to cholinergic 
agents and this hypotensive effect was 
partially blocked by anticholinergic drug, 
atropine, in anesthetized dogs.  In-vitro 
tissue experiments showed the 
antispasmodic and curare like actions of the 
test drug. 
 
From these experimental findings, the 
usefulness of Cardiospernum halicacabum 
decoction in rheumatism, nervous diseases, 
pain and as diuretic in Ayurveda is being 
substantiated. 
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